Podcasts about American Lung Association

Rachel Sanford, Manager of Health Promotions for the American Lung Association in Missouri joins Megan Lynch.

Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and screening processes. Transcript Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational Book. I'm Dr. Nate Pennell, the co-director of the Cleveland Clinic Lung Cancer Program and vice chair of clinical research for the Taussig Cancer Center. I'm also the editor-in-chief for the ASCO Educational Book.  Lung cancer is one of the leading causes of cancer-related mortality worldwide, and most cases are diagnosed at advanced stages where curative treatment options are limited. On the opposite end, early-stage lung cancers are very curable. If only we could find more patients at that early stage, an approach that has revolutionized survival for other cancer types such as colorectal and breast cancer.  On today's episode, I'm delighted to be joined by Dr. Cheryl Czerlanis, a professor of medicine and thoracic medical oncologist at the University of Wisconsin Carbone Cancer Center, to discuss her article titled, "Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening." The article was recently published in the ASCO Educational Book and featured in an Education Session at the 2025 ASCO Annual Meeting. Our full disclosures are available in the transcript of this episode.  Cheryl, it's great to have you on the podcast today. Thanks for being here. Dr. Cheryl Czerlanis: Thanks, Nate. It's great to be here with you. Dr. Nate Pennell: So, I'd like to just start by asking you a little bit about the importance of lung cancer screening and what evidence is there that lung cancer screening is beneficial. Dr. Cheryl Czerlanis: Thank you. Lung cancer screening is extremely important because we know that lung cancer survival is closely tied to stage at diagnosis. We have made significant progress in the treatment of lung cancer, especially over the past decade, with the introduction of immunotherapies and targeted therapies based on personalized evaluation of genomic alterations. But the reality is that outside of a lung screening program, most patients with lung cancer present with symptoms related to advanced cancer, where our ability to cure the disease is more limited.  While lung cancer screening has been studied for years, the National Lung Screening Trial, or the NLST, first reported in 2011 a significant reduction in lung cancer deaths through screening. Annual low-dose CT scans were performed in a high-risk population for lung cancer in comparison to chest X-ray. The study population was comprised of asymptomatic persons aged 55 to 74 with a 30-pack-year history of smoking who were either active smokers or had quit within 15 years. The low-dose CT screening was associated with a 20% relative risk reduction in lung cancer-related mortality. A similar magnitude of benefit was also reported in the NELSON trial, which was a large European randomized trial comparing low-dose CT with a control group receiving no screening. Dr. Nate Pennell: So, this led, of course, to approval from CMS (Centers for Medicare and Medicaid Services) for lung cancer screening in the Medicare population, probably about 10 years ago now, I think. And there are now two major trials showing an unequivocal reduction in lung cancer-related mortality and even evidence that it reduces overall mortality with lung cancer screening. But despite this, lung cancer screening rates are very low in the United States. So, first of all, what's going on? Why are we not seeing the kinds of screening rates that we see with mammography and colonoscopy? And what are the barriers to that here? Dr. Cheryl Czerlanis: That's a great question. Thank you, Nate. In the United States, recruitment for lung cancer screening programs has faced numerous challenges, including those related to socioeconomic, cultural, logistical, and even racial disparities. Our current lung cancer screening guidelines are somewhat imprecise and often fail to address differences that we know exist in sex, smoking history, socioeconomic status, and ethnicity. We also see underrepresentation in certain groups, including African Americans and other minorities, and special populations, including individuals with HIV. And even where lung cancer screening is readily available and we have evidence of its efficacy, uptake can be low due to both provider and patient factors. On the provider side, barriers include having insufficient time in a clinic visit for shared decision-making, fear of missed test results, lack of awareness about current guidelines, concerns about cost, potential harms, and evaluating both true and false-positive test results.  And then on the patient side, barriers include concerns about cost, fear of getting a cancer diagnosis, stigma associated with tobacco smoking, and misconceptions about the treatability of lung cancer. Dr. Nate Pennell: I think those last two are really what make lung cancer unique compared to, say, for example, breast cancer, where there really is a public acceptance of the value of mammography and that breast cancer is no one's fault and that it really is embraced as an active way you can take care of yourself by getting your breast cancer screening. Whereas in lung cancer, between the stigma of smoking and the concern that, you know, it's a death sentence, I think we really have some work to be made up, which we'll talk about in a minute about what we can do to help improve this.  Now, that's in the U.S. I think things are probably, I would imagine, even worse when we leave the U.S. and look outside, especially at low- and middle-income countries. Dr. Cheryl Czerlanis: Yes, globally, this issue is even more complex than it is in the United States. Widespread implementation of low-dose CT imaging for lung cancer screening is limited by manpower, infrastructure, and economic constraints. Many low- and middle-income countries even lack sufficient CT machines, trained personnel, and specialized facilities for accurate and timely screenings. Even in urban centers with advanced diagnostic facilities, the high screening and follow-up care costs can limit access. Rural populations face additional barriers, such as geographic inaccessibility of urban centers, transportation costs, language barriers, and mistrust of healthcare systems. In addition, healthcare systems in these regions often prioritize infectious diseases and maternal health, leaving limited room for investments in noncommunicable disease prevention like lung cancer screening. Policymakers often struggle to justify allocating resources to lung cancer screening when immediate healthcare needs remain unmet. Urban-rural disparities exacerbate these challenges, with rural regions frequently lacking the infrastructure and resources to sustain screening programs. Dr. Nate Pennell: Well, it's certainly an intimidating problem to try to reduce these disparities, especially between the U.S. and low- and middle-income countries. So, what are some of the potential solutions, both here in the U.S. and internationally, that we can do to try to increase the rates of lung cancer screening? Dr. Cheryl Czerlanis: The good news is that we can take steps to address these challenges, but a multifaceted approach is needed. Public awareness campaigns focused on the benefits of early detection and dispelling myths about lung cancer screening are essential to improving participation rates. Using risk-prediction models to identify high-risk individuals can increase the efficiency of lung cancer screening programs. Automated follow-up reminders and screening navigators can also ensure timely referrals and reduce delays in diagnosis and treatment. Reducing or subsidizing the cost of low-dose CT scans, especially in low- or middle-income countries, can improve accessibility. Deploying mobile CT scanners can expand access to rural and underserved areas.  On a global scale, integrating lung cancer screening with existing healthcare programs, such as TB or noncommunicable disease initiatives, can enhance resource utilization and program scalability. Implementing lung cancer screening in resource-limited settings requires strategic investment, capacity building, and policy interventions that prioritize equity. Addressing financial constraints, infrastructure gaps, and sociocultural barriers can help overcome existing challenges. By focusing on cost-effective strategies, public awareness, and risk-based eligibility criteria, global efforts can promote equitable access to lung cancer screening and improve outcomes.  Lastly, as part of the medical community, we play an important role in a patient's decision to pursue lung cancer screening. Being up to date with current lung cancer screening recommendations, identifying eligible patients, and encouraging a patient to undergo screening often is the difference-maker. Electronic medical record (EMR) systems and reminders are helpful in this regard, but relationship building and a recommendation from a trusted provider are really essential here. Dr. Nate Pennell: I think that makes a lot of sense. I mean, there are technology improvements. For example, our lung cancer screening program at The Cleveland Clinic, a few years back, we finally started an automated best practice alert in our EMR for patients who met the age and smoking requirements, and it led to a six-fold increase in people referred for screening. But at the same time, there's a difference between just getting this alert and putting in an order for lung cancer screening and actually getting those patients to go and actually do the screening and then follow up on it. And that, of course, requires having that relationship and discussion with the patient so that they trust that you have their best interests. Dr. Cheryl Czerlanis: Exactly. I think that's important. You know, certainly, while technology can aid in bringing patients in, there really is no substitute for trust-building and a personal relationship with a provider. Dr. Nate Pennell: I know that there are probably multiple examples within the U.S. where health systems or programs have put together, I would say, quality improvement projects to try to increase lung cancer screening and working with their community. There's one in particular that you discuss in your paper called the "End Lung Cancer Now" initiative. I wonder if you could take us through that. Dr. Cheryl Czerlanis: Absolutely. "End Lung Cancer Now" is an initiative at the Indiana University Simon Comprehensive Cancer Center that has the vision to end suffering and death from lung cancer in Indiana through education and community empowerment. We discuss this as a paradigm for how community engagement is important in building and scaling a lung cancer screening program.  In 2023, the "End Lung Cancer Now" team decided to focus its efforts on scaling and transforming lung cancer screening rates in Indiana. They developed a task force with 26 experts in various fields, including radiology, pulmonary medicine, thoracic surgery, public health, and advocacy groups. The result of this work is an 85-page blueprint with key recommendations that any system and community can use to scale lung cancer screening efforts. After building strong infrastructure for lung cancer screening at Indiana University, they sought to understand what the priorities, resources, and challenges in their communities were. To do this, they forged strong partnerships with both local and national organizations, including the American Lung Association, American Cancer Society, and others. In the first year, they actually tripled the number of screening low-dose CTs performed in their academic center and saw a 40% increase system-wide. One thing that I think is the most striking is that through their community outreach, they learned that most people prefer to get medical care close to home within their own communities. Establishing a way to support the local infrastructure to provide care became far more important than recruiting patients to their larger system.  In exciting news, "End Lung Cancer Now" has partnered with the IU Simon Comprehensive Cancer Center and IU Health to launch Indiana's first and only mobile lung screening program in March of 2025. This mobile program travels around the state to counties where the highest incidence of lung cancer exists and there is limited access to screening. The mobile unit parks at trusted sites within communities and works in partnership, not competition, with local health clinics and facilities to screen high-risk populations. Dr. Nate Pennell: I think that sounds like a great idea. Screening is such an important thing that it doesn't necessarily have to be owned by any one particular health system for their patients. I think. And I love the idea of bringing the screening to patients where they are. I can speak to working in a regional healthcare system with a main campus in the downtown that patients absolutely hate having to come here from even 30 or 40 minutes away, and they'd much rather get their care locally. So that makes perfect sense.  So, under the current guidelines, there are certainly things that we can do to try to improve capturing the people that meet those. But are those guidelines actually capturing enough patients with lung cancer to make a difference? There certainly are proposals within patient advocacy communities and even other countries where there's a large percentage of non-smokers who perhaps get lung cancer. Can we expand beyond just older, current and heavy smokers to identify at-risk populations who could benefit from screening? Dr. Cheryl Czerlanis: Yes, I think we can, and it's certainly an active area of research interest. We know that tobacco is the leading cause of lung cancer worldwide. However, other risk factors include secondhand smoke, family history, exposure to environmental carcinogens, and pulmonary diseases like COPD and interstitial lung disease. Despite these known associations, the benefit of lung cancer screening is less well elucidated in never-smokers and those at risk of developing lung cancer because of family history or other risk factors. We know that the eligibility criteria associated with our current screening guidelines focus on age and smoking history and may miss more than 50% of lung cancers. Globally, 10% to 25% of lung cancer cases occur in never-smokers. And in certain parts of the world, like you mentioned, Nate, such as East Asia, many lung cancers are diagnosed in never-smokers, especially in women. Risk-prediction models use specific risk factors for lung cancer to enhance individual selection for screening, although they have historically focused on current or former smokers.  We know that individuals with family members affected by lung cancer have an increased risk of developing the disease. To this end, several large-scale, single-arm prospective studies in Asia have evaluated broadening screening criteria to never-smokers, with or without additional risk factors. One such study, the Taiwan Lung Cancer Screening in Never-Smoker Trial, was a multicenter prospective cohort study at 17 medical centers in Taiwan. The primary outcome of the TALENT trial was lung cancer detection rate. Eligible patients aged 55 to 75 had either never smoked or had a light and remote smoking history. In addition, inclusion required one or more of the following risk factors: family history of lung cancer, passive smoke exposure, history of TB or COPD, a high cooking index, which is a metric that quantifies exposure to cooking fumes, or a history of cooking without ventilation. Participants underwent low-dose CT screening at baseline, then annually for 2 years, and then every 2 years for up to 6 years. The lung cancer detection rate was 2.6%, which was higher than that reported in the NLST and NELSON trials, and most were stage 0 or I cancers. Subsequently, this led to the Taiwan Early Detection Program for Lung Cancer, a national screening program that was launched in 2022, targeting 2 screening populations: individuals with a heavy history of smoking and individuals with a family history of lung cancer.  We really need randomized controlled trials to determine the true rates of overdiagnosis or finding cancers that would not lead to morbidity or mortality in persons who are diagnosed, and to establish whether the high lung detection rates are associated with a decrease in lung cancer-related mortality in these populations. However, the implementation of randomized controlled low-dose CT screening trials in never-smokers has been limited by the need for large sample sizes, lengthy follow-up, and cost.  In another group potentially at higher risk for developing lung cancer, the role of lung cancer screening in individuals who harbor germline pathogenic variants associated with lung cancer also needs to be explored further. Dr. Nate Pennell: We had this discussion when the first criteria came out because there have always been risk-based calculators for lung cancer that certainly incorporate smoking but other factors as well and have discussion about whether we should be screening people based on their risk and not just based on discrete criteria such as smoking. But of course, the insurance coverage for screening, you have to fit the actual criteria, which is very constrained by age and smoking history. Do you think in the U.S. there's hope for broadening our screening beyond NLST and NELSON criteria? Dr. Cheryl Czerlanis: I do think at some point there is hope for broadening the criteria beyond smoking history and age, beyond the criteria that we have typically used and that is covered by insurance. I do think it will take some work to perhaps make the prediction models more precise or to really understand who can benefit. We certainly know that there are many patients who develop lung cancer without a history of smoking or without family history, and it would be great if we could diagnose more patients with lung cancer at an earlier stage. I think this will really count on there being some work towards trying to figure out what would be the best population for screening, what risk factors to look for, perhaps using some new technologies that may help us to predict who is at risk for developing lung cancer, and trying to increase the group that we study to try and find these early-stage lung cancers that can be cured. Dr. Nate Pennell: Part of the reason we, of course, try to enrich our population is screening works better when you have a higher pretest probability of actually having cancer. And part of that also is that our technology is not that great. You know, even in high-risk patients who have CT scans that are positive for a screen, we know that the vast majority of those patients with lung nodules actually don't have lung cancer. And so you have to follow them, you have to use various models to see, you know, what the risk, even in the setting of a positive screen, is of having lung cancer.  So, why don't we talk about some newer tools that we might use to help improve lung cancer screening? And one of the things that everyone is super excited about, of course, is artificial intelligence. Are there AI technologies that are helping out in early detection in lung cancer screening? Dr. Cheryl Czerlanis: Yes, that's a great question. We know that predicting who's at risk for lung cancer is challenging for the reasons that we talked about, knowing that there are many risk factors beyond smoking and age that are hard to quantify. Artificial intelligence is a tool that can help refine screening criteria and really expand screening access. Machine learning is a form of AI technology that is adept at recognizing patterns in large datasets and then applying the learning to new datasets. Several machine learning models have been developed for risk stratification and early detection of lung cancer on imaging, both with and without blood-based biomarkers. This type of technology is very promising and can serve as a tool that helps to select individuals for screening by predicting who is likely to develop lung cancer in the future.  A group at Massachusetts General Hospital, represented in our group for this paper by my co-authors, Drs. Fintelmann and Chang, developed Sybil, which is an open-access 3D convolutional neural network that predicts an individual's future risk of lung cancer based on the analysis of a single low-dose CT without the need for human annotation or other clinical inputs. Sybil and other machine learning models have tremendous potential for precision lung cancer screening, even, and perhaps especially, in settings where expert image interpretation is unavailable. They could support risk-adapted screening schedules, such as varying the frequency and interval of low-dose CT scans according to individual risk and potentially expand lung cancer screening eligibility beyond age and smoking history. Their group predicts that AI tools like Sybil will play a major role in decoding the complex landscape of lung cancer risk factors, enabling us to extend life-saving lung cancer screening to all who are at risk. Dr. Nate Pennell: I think that that would certainly be welcome. And as AI is working its way into pretty much every aspect of life, including medical care, I think it's certainly promising that it can improve on our existing technology.  We don't have to spend a lot of time on this because I know it's a little out of scope for what you covered in your paper, but I'm sure our listeners are curious about your thoughts on the use of other types of testing beyond CT screening for detecting lung cancer. I know that there are a number of investigational and even commercially available blood tests, for example, for detection of lung cancer, or even the so-called multi-cancer detection blood tests that are now being offered, although not necessarily being covered by insurance, for multiple types of cancer, but lung cancer being a common cancer is included in that. So, what do you think? Dr. Cheryl Czerlanis: Yes, like you mentioned, there are novel bioassays such as blood-based biomarker testing that evaluate for DNA, RNA, and circulating tumor cells that are both promising and under active investigation for lung cancer and multi-cancer detection. We know that such biomarker assays may be useful in both identifying lung cancers but also in identifying patients with a high-risk result who should undergo lung cancer screening by conventional methods. Dr. Nate Pennell: Anything that will improve on our rate of screening, I think, will be welcome. I think probably in the future, it will be some combination of better risk prediction and better interpretation of screening results, whether those be imaging or some combination of imaging and biomarkers, breath-based, blood-based. There's so much going on that it is pretty exciting, but we're still going to have to overcome the stigma and lack of public support for lung cancer screening if we're going to move the needle. Dr. Cheryl Czerlanis: Yes, I think moving the needle is so important because we know lung cancer is still a very morbid disease, and our ability to cure patients is not where we would like it to be. But I do believe there's hope. There are a lot of motivated individuals and groups who are passionate about lung cancer screening, like myself and my co-authors, and we're just happy to be able to share some ways that we can overcome the challenges and really try and make an impact in the lives of our patients. Dr. Nate Pennell: Well, thank you, Dr. Czerlanis, for joining me on the By the Book Podcast today and for all of your work to advance care for patients with lung cancer. Dr. Cheryl Czerlanis: Thank you, Dr. Pennell. It's such a pleasure to be with you today. Thank you. Dr. Nate Pennell: And thank you to our listeners for joining us today. You'll find a link to Dr. Czerlanis' article in the transcript of this episode.  Please join us again next month for By the Book's next episode and more insightful views on topics you'll be hearing at the education sessions from ASCO meetings throughout the year, and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:     Dr. Nathan Pennell    @n8pennell   @n8pennell.bsky.social Dr. Cheryl Czerlanis Follow ASCO on social media:     @ASCO on X (formerly Twitter)     ASCO on Bluesky    ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Nate Pennell:        Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron       Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi    Dr. Cheryl Czerlanis: Research Funding (Institution): LungLife AI, AstraZeneca, Summit Therapeutics

Biodiesel is growing in the Midwest, and Illinois is a primary example. The folks accelerating biodiesel programs just south of us also want to see Wisconsin expand biodiesel usage. Stephanie Hoff was recently in Illinois and Chicagoland with Clean Fuels Alliance America, looking at the whole chain of biodiesel production from the beans getting dropped off at the plant to riding on a boat on the Chicago River that runs on biodiesel. The state has tax incentives for using biodiesel, and it’s also helping advance sustainability goals. Pete Probst is the president of Indiginous Energy, which is a renewable energy consultant, working with groups like the Illinois Soybean Association and the Chicago Park District. Pete tells Stephanie Hoff that he loves renewable diesel so much, he rigged up his own ride back in the day to run on used cooking oil. He also talks about his role helping members of the B20 Club -- a partnership between the Illinois Soybean Association checkoff and the American Lung Association. It supports fleets running on biodiesel blends of 20 percent or higher. More showers possible today, but it's the wind you'll likely notice. That's the update from Stu Muck. Summer camp is something many kids look forward to. While the initial goal might be just having fun, it doesn't hurt to include some educational experiences too. Ben Jarboe finds out about the 4-H Summer Academy. It offers attendees a variety of track-based activities, seminars, campus tours, performances, and hands-on experiences. Summer Academy will be held at the UW-Madison Campus, where youth and adult chaperones will stay at Sellery Residence hall. Youth will be participating in a wide variety of track-based activities and seminars. They will be able to visit different locations on Campus and in Madison. They will also have the opportunity to hear from speakers, watch a performance from the 4-H Drama Company, and participate in a variety of fun hands-on activities! Polk County 4-H Agent, Lindsay Spindler, about why she's excited to be a part of the event.The spirit of June Dairy celebrations is crossing in waves across the state, but what about taking the enthusiasm outside the state? In this edition of Dairy Farmers of Wisconsin discussion, Pam Jahnke finds out about the value that trade shows bring to dairy producers. Samantha Castro is the Director - Buyer Missions & Trade Shows at Dairy Farmers of Wisconsin. The volume of people and decision makers that can be reached at one trade show helps move the needle on product placement and ingredient inclusion for a lot of Wisconsin dairy processors. She explains how they use limited trade floor space to make sure they're involving Wisconsin cheesemakers in telling the story. Paid for by Dairy Farmers of Wisconsin.See omnystudio.com/listener for privacy information.

According to the American Lung Association's annual State of the Air report, at least 156 million Americans – 46% of the population – live with unsafe levels of ozone, particulate pollution, or both. The report analyzed ozone and particulate pollution levels between 2021 and 2023, during which the worst wildfire season on record took place […]

Nearly half of Americans are now breathing unhealthy air — and much of Pennsylvania is among the hardest-hit, according to the American Lung Association’s newly released 2025 State of the Air report. The annual analysis, now in its 26th year, found significant declines in air quality across the state, with Lancaster, Pittsburgh, and Dauphin counties receiving failing grades for both ozone and fine particle pollution.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

In this NightSide News Update we chatted with: Alan Arnette, a mountaineer and climbing coach with over 30 years climbing experience – Discussing challenges climbing Mt. Everest and the cost.Dr. Rebecca Robbins, a sleep expert and researcher at Mass General Brigham and Harvard Medical School - Discussing how hitting the snooze button might not be in your best interest!Dr. David Hill, member of the Lung Association's National Board of Directors, immediate past chair of the Northeast Regional Board of the American Lung Association, and a practicing pulmonary and critical care physician - Discussing the results from the 2025 “State of the Air” report done by the American Lung Association.John Judge, CEO of Scouting Boston - Discussing Scouting America and Scouting Boston name change and upcoming event honoring two outstanding supporters.You can hear NightSide with Dan Rea, Live! Weeknights From 8PM-12AM on WBZ NewsRadio on the #iHeartRadio app!

This special episode features 2 interviews on-site at the 2025 American Thoracic Society (ATS) International Conference in San Francisco: Harold P. Wimmer, CEO of the American Lung Association, and Francesca Polverino, MD, PhD, a professor at Baylor College of Medicine and spokesperson for the ALA. View the latest conference coverage from this meeting here: https://www.hcplive.com/conference/ats #Lungcast #HealthNews

Senior Director of Advisory at the American Lung Association, JoAnna Strothers comes in to talk about the "State of Air Report". Which talks about the ozone levels and particles that create air pollution. Albuquerque, comes in at #22 in the top 25 most polluted in the Nation. All on News Radio KKOB See omnystudio.com/listener for privacy information.

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the VESTIGE trial and their implications on asthma care.  Uncover: ·      The importance of patient phenotyping: How can biomarkers and imaging improve asthma management? ·      Mucus plugging and airflow obstruction: What does the latest research reveal? ·      Biologics and airway remodeling: What did the VESTIGE trial reveal about biologics and airway remodeling? ·      The role of imaging in clinical practice: How can CT scans provide new insights into asthma care? Speakers Mario Castro, University of Kansas School of Medicine, United States Njira Lugogo, University of Michigan, Ann Arbor, Michigan, United States Disclaimers: ·      This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ·      The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program ·      The content contained in this program was jointly developed by AMJ, the speakers, and Sanofi and Regeneron, and is not eligible for continuing medical education (CME) credits ·      See full US Prescribing Information for dupilumab ·      MAT-US-2412937 v2.0 - Pro1 Expiration Date: 04/21/2026 Speaker disclosures: ·      MC reports research support from the American Lung Association, AstraZeneca, Gala Therapeutics, Genentech, GSK, NIH, Novartis, PCORI, Pulmatrix, sanofi-aventis, Shionogi, and Theravance Biopharma, consultancy fees from Allakos, Amgen, Arrowhead Pharmaceuticals, Blueprint Medicines, Connect BioPharma, Genentech, GSK, Merck, Novartis, OM Pharma, Pfizer, Pioneering Medicines, sanofi-aventis, Teva, Third Rock Ventures, and Verona Pharmaceuticals, speaker fees from Amgen, AstraZeneca, Regeneron Pharmaceuticals Inc., and Sanofi, and royalties from Aer Therapeutics. ·      NLL reports research support paid to institution from Amgen, AstraZeneca, Avillion, Genentech, Gossamer Bio, GSK, Regeneron Pharmaceuticals Inc., Sanofi, and Teva, consultancy fees from and participation on advisory boards with Amgen, AstraZeneca, Genentech, GSK, Novartis, Regeneron Pharmaceuticals Inc., Sanofi, and Teva, travel support from AstraZeneca, and honoraria for non-speaker bureau presentations from AstraZeneca and GSK. References: 1.        Castro M et al. Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir Med. 2025;13:208-20. doi: 10.1016/S2213-2600(24)00362-X.

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the VESTIGE trial and their implications on asthma care.  Uncover: ·      The importance of patient phenotyping: How can biomarkers and imaging improve asthma management? ·      Mucus plugging and airflow obstruction: What does the latest research reveal? ·      Biologics and airway remodeling: What did the VESTIGE trial reveal about biologics and airway remodeling? ·      The role of imaging in clinical practice: How can CT scans provide new insights into asthma care? Speakers Mario Castro, University of Kansas School of Medicine, United States Njira Lugogo, University of Michigan, Ann Arbor, Michigan, United States Disclaimers: ·      This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ·      The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program ·      The content contained in this program was jointly developed by AMJ, the speakers, and Sanofi and Regeneron, and is not eligible for continuing medical education (CME) credits ·      See full US Prescribing Information for dupilumab ·      MAT-US-2412937 v2.0 - Pro1 Expiration Date: 04/21/2026 Speaker disclosures: ·      MC reports research support from the American Lung Association, AstraZeneca, Gala Therapeutics, Genentech, GSK, NIH, Novartis, PCORI, Pulmatrix, sanofi-aventis, Shionogi, and Theravance Biopharma, consultancy fees from Allakos, Amgen, Arrowhead Pharmaceuticals, Blueprint Medicines, Connect BioPharma, Genentech, GSK, Merck, Novartis, OM Pharma, Pfizer, Pioneering Medicines, sanofi-aventis, Teva, Third Rock Ventures, and Verona Pharmaceuticals, speaker fees from Amgen, AstraZeneca, Regeneron Pharmaceuticals Inc., and Sanofi, and royalties from Aer Therapeutics. ·      NLL reports research support paid to institution from Amgen, AstraZeneca, Avillion, Genentech, Gossamer Bio, GSK, Regeneron Pharmaceuticals Inc., Sanofi, and Teva, consultancy fees from and participation on advisory boards with Amgen, AstraZeneca, Genentech, GSK, Novartis, Regeneron Pharmaceuticals Inc., Sanofi, and Teva, travel support from AstraZeneca, and honoraria for non-speaker bureau presentations from AstraZeneca and GSK. References: 1.        Castro M et al. Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir Med. 2025;13:208-20. doi: 10.1016/S2213-2600(24)00362-X.

Dancing since the age of 5, Sybil Stanonis' first love was tap. Taking classes and competing with top level recognition in tap, ballet and jazz throughout childhood; she knew dance was a passion. Her competition success provided her invitations to dance across Russia (Leningrad, Minsk, Moscow ) and Denmark (Tivoli Gardens, Copenhagen). Her professional credits include 2 seasons as a NFL Cheerleader for the Tampa Bay Buccaneers which involved promotional work and community events. While pursuing & completing her degree in psychology at State University of New York (SUNY) Old Westbury she continued dance by adding to her professional credits dancing with the Knicks City Dancers summer dance events, coaching high school cheerleading and performing with the Fred Astaire Dance Troupe on Long Island, NY. Moving to Florida and starting a family has shifted Sybil's dance career to instruction/dance therapy.  The curriculum Sybil developed from her education, dance expertise & life experience offers a creative and therapetic approach that teaches skills to last a lifetime. DTWS is currently offered in studio and public & private schools, virtual and also at your location site for team building experiences. Dance Time with Sybil, Inc. is a patch partner with Girl Scouts of West Central Florida & community partner with numerous organizations.  Sybil & her students students perform for various charity events around the Tampa Bay Area including Wounded Warriors Benefit, Hillsborough County Anti-Drug Alliance, Drug Free America Foundation, Drug Enforcement Administration, Central Florida Behavioral Health Network, & American Lung Association.  Sybil also stays active with the Tampa Bay Buccaneer Cheerleader Alumni & NFL Alumni through performances and community events. Sybil is an official Tedx speaker sharing her speech "Dancing through the Darkness with Pivots to your Purpose" with inspiration, motivation & movement. "To Me dancing is a beautiful way of expressing your thoughts, emotions and feelings through movement of our body...There is never any judgement on my dance floor...and it will forever be a part of my journey we call life." Find her on social media:  Facebook : Sybil Stanonis and Dance Time with Sybil Instagram: sybs99 TikTok: dtwsybil LinkedIn: sybil stanonis or dtwsybil Sybil's Website: https://dtwsybil.com HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast   PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/

Mikayla Pittman, Manager of Nationwide Lung Cancer Screening for the American Lung Association, joins Lisa Dent to discuss the rise of lung cancer in those who have never smoked.

Andrea's inspiring journey from interior design to public health is a testament to the power of personal experience in shaping professional paths. Prompted by her son's asthma diagnosis and the challenges they faced navigating the healthcare system, Andrea became a Certified Health Education Specialist and Asthma Educator. Through her story, we uncover the emotional resilience required to manage a child's chronic illness and the unwavering trust in parental instincts that guided her towards advocating for better asthma education and specialized care.Medicine shaming and the prevalence of misleading health advice online pose significant challenges for those managing chronic conditions like asthma. Andrea shares her candid experiences with unsolicited advice and the pitfalls of miracle cures, highlighting the critical importance of consulting healthcare professionals and relying on accurate, reputable sources. We also reflect on outdated misconceptions about asthma and the necessity for precise diagnoses and treatments, especially considering the pervasive myths from the 1980s that continue to influence public perception.Creating an asthma-friendly home is crucial for effective management of the condition, and Andrea offers practical strategies to achieve this. From reducing allergens with specific cleaning techniques to ensuring family members are prepared for medical emergencies, she provides actionable tips to maintain a healthy environment. We also delve into the importance of balancing asthma management with quality of life, discussing how to enjoy simple pleasures while minimizing health risks. Andrea's insights empower listeners to make informed decisions that positively impact their lives and those of their loved ones.A few reasons you should care about asthma:Asthma is the most common chronic disease among children Asthma is the #1 cause of missed school days (and kids with asthma grow up to be adults with asthma.)10 people in the U.S. die each day from asthma I love the famous statistics quote by Paul Badeur, "Statistics are human beings with the tears wiped off."American Lung Association https://www.lung.org/Asthma and Allergy Foundation of America https://aafa.org/Allergy & Asthma NetworSend us a text Are you living with a chronic illness and want to make your voice heard? Rare Patient Voice connects patients and caregivers with research opportunities—so you can share your experiences and get paid for your time! Your insights help drive real change in healthcare.Let's Get Started - Rare Patient Voice

The latest “State of the Air” report by the American Lung Association finds that nearly half of people living in the U.S. breathe unhealthy levels of air pollution. Soot and smog are on the rise in part because climate change is bringing more wildfires and ozone-forming conditions. Also, a key climate modeling program within the National Oceanic and Atmospheric Administration or NOAA is slated for near-elimination, according to a draft White House memo. That could have consequences for weather forecasting, disaster preparedness, agriculture, military operations and more. Plus - parakeets have astounding vocal abilities and are able to mimic as many as 1700 human words. And their brains may provide insight into how we humans talk. In a recent study, researchers found human-like neural activity during vocalization. They hope this research may help shed light on communication disorders in humans such as autism. ***Join us on Zoom Thursday, May 8 at 8 p.m. Eastern for the next Living on Earth Book Club event! Catherine Coleman Flowers, author of Holy Ground, will talk with Host Steve Curwood about activism, environmental justice, and finding hope. Learn more and register at loe.org/events.*** Learn more about your ad choices. Visit megaphone.fm/adchoices

Dallas-Fort Worth is among the most ozone-polluted metro areas in the U.S. That's according to new data from the American Lung Association. The 26th annual State of the Air report ranked D-FW as No. 10 out of 228 metropolitan areas for worst high ozone days — a setback from previous rankings. In other news, a man is in jail and facing murder charges after Dallas police connected two separate shootings by tying bullet casings, a cellphone number and a vehicle to both scenes, records show. 30-year old Garrett Hudgens is facing murder charges in connection with fatal shootings on April 4 in West Oak Cliff and April 23 near Fair Park; a novel experiment underway in West Texas could help determine whether long-abandoned nuclear technology could be the future of Texas power. At Abilene Christian University, a research lab is working to create the nation's first nuclear research reactor in more than 40 years; and the Dallas Stars needed a response, and it couldn't have come in more convincing fashion. Scoring just nine seconds into Game 5 at American Airlines Center, the Stars showed up from the start and took down the Colorado Avalanche 6-2 on Monday to take a 3-2 series lead. The Stars will have the chance to end the series Thursday night in Game 6 at Colorado. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Carrie Nyssen, Senior Director of Advocacy at the American Lung Association in Oregon, joins the Exchange.

On the "CBS News Weekend Roundup," host Allison Keyes has the latest on hundreds of millions in grants to community organizations including some that help crime victims from CBS's Scott MacFarlane. We have team coverage of the global goodbyes for Pope Francis, and what some want to see in the next pope.  In the "Kaleidoscope with Allison Keyes" segment, a discussion about the American Lung Association's 2025 State of the Air report, which shows that nearly half of the people in the nation are breathing unhealthy levels of pollution. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Sign up for our newsletter! Cement is the glue that keeps concrete together, and it has a big carbon footprint. That's a problem for a warming planet. A Johnstown-based mining company has gotten the go-ahead to expand an underground coal mine in Westmoreland County. The site of a demolished coal-fired power plant is being redeveloped to build a massive gas-fired power plant and data center. The American Lung Association gave Pittsburgh's air quality an "F" in its latest annual report. Proponents of sustainable fashion hope tariffs on cheap clothes from overseas will turn consumers on to thrift shopping. Autistic students at a Philly public school are learning life skills by growing their own food. Trump administration cuts are hitting small organic farmers, including freezing a project to jumpstart the production of flax. Students in Pennsylvania's Trout in the Classroom program. recently said goodbye to their aquatic classmates. We're independent and non-profit, and we don't get money from WESA, WPSU or any other radio station. So we must turn to you, our listeners, for support. Take action today so we can continue to keep you informed.  Donate today.  Or send us a check to: The Allegheny Front, 67 Bedford Square, Pittsburgh, 15203.  And thanks! 

Remember that 2020 pandemic "fresh air" vibe, that summer? How crisper, clearer and cleaner the air over Atlanta seemed? Well since then we've of course regressed; that's according to new American Lung Association report cards. Atlanta, in particular, slipped from C to F. On to discuss the results and speculate as to what could be done to reverse the trend, along with some disturbing signals in the current political climate, the ALA's Danna Thompson. ------The field appears to have cleared (so far, anyway) for Senator Jason Esteves to be the Democratic gubernatorial option in 2026, but who else is out there? I touch on it a little, with thanks to some savvy "Politically Georgia" reporting. ------All the talk about development and traffic and how Georgia and metro Atlanta addresses (or doesn't) its mass transit needs, it's interesting that this social media post crossed my radar. The message? "Bigger Isn't necessarily better." "Should cities focus on growing their population, jobs, and development?Absolutely not."I weigh in.------Lastly, a venerable voice on the left took her final bow on the radio Wednesday. Here's to Randi Rhodes ... with some well wishes.

Morgantown Third Ward councilor Weez Michael on the community clean up in DOH right-of-way areas. Also, the Morgantown Municipal Election Director of Advocacy for the American Lung Association on the State of the Air Report 

Bradley Busby joined the show to discuss the American Lung Association's recent report on Ozone pollution in the Valley. Busby discussed what Ozone is and why Maricopa failed according to this report.

Kristina Hamilton, Director of Advocacy for the American Lung Association in Illinois, joins Lisa Dent to discuss Chicago’s air pollution. A 2025 report shows that Chicago has some of the worst air quality in the country. Hamilton shares possible measures that could help improve the air quality in Chicago.

(AURN News) — How clean is your air? The American Lung Association released its latest report this week that includes the most polluted cities in the United States, revealing surprising locations impacted by significant air pollution. Cities were ranked based on ozone pollution, year-round particle pollution, and short-term particle pollution. Leading the list for ozone pollution is Los Angeles-Long Beach, California. Visalia, California, followed closely, along with Bakersfield-Delano, California; Phoenix-Mesa, Arizona; and Fresno-Hanford-Corcoran, California. Completing the top 10 are Denver-Aurora-Greeley, Colorado; Houston-Pasadena, Texas; San Diego-Chula Vista-Carlsbad, California; Salt Lake City-Provo-Orem, Utah-Idaho; and Dallas-Fort Worth, Texas-Oklahoma. California dominated the rankings for year-round particle pollution, with Bakersfield-Delano listed first, followed by Visalia and Fresno-Hanford-Corcoran. According to the American Lung Association, air pollution can cause a variety of health issues ranging from wheezing and coughing to asthma and even lung cancer. Other potential health problems include heart attacks, strokes, and premature death. The organization also says that ozone is a lung irritant, and exposure can negatively affect respiratory health and potentially shorten lifespans. Learn more about your ad choices. Visit megaphone.fm/adchoices

Director of environmental health at the American Lung Association, Kevin Stewart, calls in to talk about the air quality in our city

Ashley Lyerly, Senior Director of Advocacy for the American Lung Association, discusses the 26th annual "State Of The Air" report, what it means, how it applies to Jacksonville, and ways we can participate in improving and sustaining our lung health.

Dr. Catherine Oseni, Pharm.D., FAAMFM, ABAAHP Dr. Catherine Oseni is a board-certified, fellowship-trained clinical integrative pharmacist with deep expertise in both traditional pharmaceuticals and the impact of supplements and herbs on the body. Her career is rooted in a unique understanding of how conventional medications interact with integrative therapies, allowing her to create safe, personalized, and effective treatment plans for her clients.   Since 2006, Dr. Oseni has provided direct client care, skillfully blending Western medicine with holistic, evidence-based approaches to address the root causes of health concerns. Her individualized care model focuses on achieving optimal wellness through natural, whole-person solutions.   Recognized by peers as a leader in functional and integrative medicine, Dr. Oseni remains at the forefront of her field by continually expanding her knowledge through ongoing education and participation in professional conferences. She is also a passionate educator, frequently speaking at national and local events for both the public and healthcare professionals to promote and advance the field of integrative medicine.   Dr. Olusegun Oseni, MD Dr. Olusegun Oseni serves as the Medical Director of Alpha Care Wellness Center and is board certified in internal medicine, pulmonary care, critical care, and sleep medicine. Originally from Nigeria, he earned his medical degree from the University of Ilorin College of Medicine before moving to the United States for postgraduate training.   He completed his residency in internal medicine and a fellowship in pulmonary medicine at Harlem Hospital Center (an affiliate of Columbia University), followed by a fellowship in critical care medicine at Montefiore Medical Center (an affiliate of Albert Einstein College of Medicine), both in New York City.   Dr. Oseni is a Fellow of the American College of Chest Physicians (FCCP), a Diplomate of the American Board of Sleep Medicine (DABSM), and an active member of the Society of Critical Care Medicine, American Lung Association, and American Medical Association. Highly respected by his peers and beloved by his patients, Dr. Oseni is known in the community for his thorough, compassionate care and unwavering commitment to improving quality of life—regardless of the complexity of the condition.

President & CEO of Mon Health Systems, Executive Vice President of Vandalia Health System David Goldberg and Ashok Aggarwal, Chief Strategy Officer at Intermed Labs on their expanded partnership. Mon EMS Executive Director Forest Weyen on upcoming public forums across the county. Laura Wiiliams from the American Lung Association and Breanna Cutright, junior from Liberty High School on Tobacco Free Day in Charleston  

In this week's episode of Pat & Aaron Overtime we're joined by The American Lung Association's Steve Riddle for all the details on the upcoming "Fight for Air Climb" that raises funds and awareness for lung health.

This is the full unedited audio of the Packaging Reduction and Recycling Infrastructure Act (PRRIA)press conference on March 19. New York State Senator Pete Harckham and Assemblymember Deborah Glick are the lead sponsors. Environmental and civic groups that participated include American Lung Association, Beyond Plastics, Capitol District Zero Waste, Environmental Advocates NY, League of Women Voters, New York League dof Conservation Voters, New York State Association of Counties, NYPIRG and Protect the Adirondacks, Riverkeeper, Sierra Club Atlantic Chapter and Sisters of Charity. Dr. Kathy Nolan, a pediatrician active with Physicians for Social Responsibility, was a featured speaker. The bill (S.1464 / A.1749), which recently advanced in both the Senate and Assembly Environmental Conservation Committee, aims to significantly reduce packaging waste by requiring companies to reduce overall packaging use, improve recyclability, fund recycling infrastructure, support municipal recycling programs, and eliminate toxins in packaging materials. The legislation has broad approval from New Yorkers according to public polling. Solid waste, which has been rising steadily over the years, presents a serious challenge for New York's environment and the health of New Yorkers, as well as a burden on taxpayers. New York State's 25 municipal solid waste landfills could be full within the next 15 years, according to the NYS Solid Waste Management Plan. Incineration of waste creates air quality issues and increases greenhouse gas emissions. Further, municipalities bear the burden of collecting, sorting, and processing waste, driving up costs for taxpayers.

Lexi Popovici who serves as Senior Manager of Clean Outdoor Air Nationwide Policy at the American Lung Association joins Megan Lynch.

Ohio spends a small fraction of the CDC's recommended funding for tobacco prevention and cessation programming.

The American Lung Association is reporting that while smoking conventional cigarettes and electronic cigarettes is on the decline among our children and teens, the use of non-combustible tobacco products known as “smokeless and spitless nicotine pouches” is growing in popularity. Thanks to marketing efforts and the viral nature of social media promotion, there has been a 641% increase in sales of products like Zyn, On!, Rouge, Velo, Juice Head, Zone, and Lucy. Research on these addictive nicotine delivery systems indicates that over a quarter of those who use them are under the age of 21. With nicotine sales limited by law to those over the age of 21, we must teach kids that God has given them the responsibility to obey the laws of the government. Finally, teach them that in First Corinthans 6:19 to 21, we learn that stewarding the health of their God-given bodies is not only their responsibility, but an act of worship.

In hour two, Hoch and Crowder discuss words that don't rhyme but flow together, and Flo Rida has a strange way of trying to rhyme Wisconsin. In Cat Talk Hoch reads the prop bet for the USA vs Canada in the 4 Nations Finals tomorrow night in Boston. Also, have you ever ordered something with double ginger or somebody that deconstructs their food? We find out Jimmy has been to a hibachi restaurant and what he orders there. Tyler Herro of the future with the Heat without Jimmy Butler and if there is growth. Hoch tells us about his trip to Bud's Chicken & Seafood. Peter Berger a Miami firefighter with COPD who has been honored by the American Lung Association joins the show to talk about his charity event Fight For Air Climb Miami on March 9 at Loan Depot Park to donate go to climbmiami.org.

About Dr. Karin Tollefson:Dr. Karin Tollefson is a highly accomplished pharmaceutical executive with over 30 years of experience dedicated to advancing cancer care. Currently serving as Chief Oncology Medical Officer at Pfizer, she leads the Oncology Global and US Medical Affairs Division. Before joining Pfizer in 2023, Dr. Tollefson held the role of Senior Vice President and Head of Global Medical Affairs at Seagen Inc., where she successfully launched three practice-changing medicines and built a global medical affairs organization. Her extensive career includes significant tenure at Eli Lilly and Company, where she held various leadership roles in clinical operations, development, and medical affairs. Throughout her career, she has contributed to the launch of eight new medicines, impacting patient care across multiple tumor types and therapeutic areas. Dr. Tollefson is an Independent Director on the Board for Verastem Oncology, and has also served on the boards of the American Lung Association and the Leukemia and Lymphoma Society. She is a 2024 Healthcare Businesswomen's Association Luminary Award recipient, and is a strong advocate for women in the oncology field, being a sponsor of both the Oncology Women's Network and the Pfizer Butterfly Community at Pfizer. She holds a Doctorate of Pharmacy from the University of Kansas and completed her undergraduate studies at Kansas State University.Things You'll Learn:The incidence of cancer in people under 50 has increased by 79% since 1990, marking a significant and alarming trend that needs immediate attention, especially with colorectal cancer now the leading cause of cancer death in men and second in women younger than 50 years. Western lifestyle factors such as poor diet, obesity, sedentary behavior, and exposure to toxins are likely significant contributors to the rise of early-onset cancers, suggesting that shifts in lifestyle and public health initiatives could impact cancer rates.Younger cancer patients are often diagnosed at later stages due to a lack of preventative care and symptoms being easily dismissed.Increased screening accessibility is crucial for early detection and prevention. This includes molecular testing and colonoscopies, which offer the opportunity to remove precancerous polyps, preventing them from developing into something more serious.The battle against cancer requires collaborative efforts between healthcare providers, academic institutions, industry partners, and advocacy organizations. This is not just one organization's fight; collaborative efforts must continue.Resources:Follow Dr. Karin Tollefson, Chief Oncology Medical Officer at Pfizer, on LinkedIn.Discover more about Pfizer on their LinkedIn and website.Read more on Pfizer in Oncology here. Patient Resources/Advocacy Links:Explore This Is Living With Cancer's Advocacy Support's website.Visit the Global Colorectal Cancer Alliance's website here. (Pfizer was one of their sponsors)Learn more about the transformative work CancerCare is doing.Find CancerCare's guide on Biomarker Testing here.Read the best practices for Biomarker Testing Coverage here. (Pfizer had input and was a sponsor)Get AONN Biomarker Navigation here. For the Precision Medicine Toolkit, look here.Empower yourself or your patients with essential navigation resources–a site co-created with AONN, to find materials on breast, prostate, health equity, geriatric, and more. (Patient navigators can download and share educational tools for enhanced support.)Deepen your understanding of prostate cancer here. 

Get ready for an inspiring conversation about the power of passion, purpose, and partnerships in evolving patient advocacy to meet the changing needs of a community! In this episode, Harold Wimmer, President and CEO of the American Lung Association, shares insights from his incredible 46-year journey with the organization. Harold reveals how the American Lung Association grew successful regional initiatives into powerful, national programs that deliver critical resources and support to lung patients across the country.  Join host Eric Racine and co-host Lisa Schmitt, US Public Affairs and Patient Advocacy Lead for Immunology at Sanofi, as they dive into the innovative programs that have defined the American Lung Association's success. Discover how the American Lung Association HelpLine, which began as a statewide service in Illinois 25 years ago, has become a lifeline for patients nationwide. Learn how the American Lung Association adapts to meet the evolving needs of its community through digital platforms, personalized support services, and bold advocacy for cleaner air.  Don't miss this episode packed with actionable lessons on driving scalable, long-term success in patient advocacy. Tune in to uncover Harold's blueprint for building meaningful partnerships and empowering patient communities like never before! 

Feb. 3, 2025 - New York could do a better job reducing smoking levels, according to the American Lung Association. We break down the anti-smoking efforts in the state and identifying where policymakers are falling short with Michael Seilback, assistant vice president of nationwide advocacy of the ALA.

Dr Anthony Gerber is a pulmonary and critical care medicine physician at National Jewish Health, where he conducts research on lung disease. He is also a professor of medicine at the University of Colorado and National Jewish and has has served on the Colorado Air Quality Control Commission. He provides insight into actions we can take in our own communities. Look up who represents you at your city, county and state level Find out how air is regulated in your state and what the most local unit to you is. Reach out to find out what they are doing to reduce pollution and greenhouse gases and find out how you can lend your voice to advocate for this and potentially push for even more action Find out if your state adheres to the California vehicle standards- if it doesn't, push your legislators to join. Tell them how you want to stimulate the economy by everyone saving money on fuel and how you want to breathe cleaner air Look up the State of the Air report from the American Lung Association to find out how your city or county scores in terms of pollution. It helps to have information when you go to local decision makers Every time someone declares for office, whether city, council or local government to represent you, reach out. Ask them what local action they envision to clean up the air and reduce greenhouse gases Find out how building codes are made in your city or county- ask what they are doing to make them more efficient while not increasing the cost of housing. Volunteer with weatherization efforts Gas Powered Lawn equipment are a hyper local source of noise and pollution - learn more at the “Yards on Fire” episode for what you can do Everyone hates sitting in traffic- find out how transportation policy is made where you are and push for options to decrease emissions, whether by getting more people out of cars and onto bikes, feet or public transportation, etc Share this episode with anyone interested in what they can do locally for healthy air and climate change. Please also consider leaving the podcast a 5 star review wherever you listen so more people discover it.  Finally, consider a donation to the American Lung Association, which works locally for clean air and climate action. ------------------------------------------------------------------- Visit blog post for more information, or go to airhealthourhealth.org. Follow and comment on Facebook page and Instagram. Episode photo by ⁠Sven Brandsma⁠ on ⁠Unsplash

On this West Virginia Morning, West Virginia's tobacco use and prevention efforts again earned failing grades on an assessment from the American Lung Association, and researchers look at the effects of the East Palestine derailment. The post State Scores Low On Smoking Cessation And Researching The East Palestine Derailment, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

Mississippi healthcare leaders unveil the state's 2024 Public Health Report Card. It shows progress is being made in a number of areas---but significant challenges remain. Then, Mississippi receives failing grades for tobacco control policies in the American Lung Association's annual “State of Tobacco Control” Report.Plus, The Alabama Black Belt received national attention for its longstanding sanitation issues for residents. One Lowndes County-based organization shows how they are working to get septic systems across Central Alabama. Hosted on Acast. See acast.com/privacy for more information.

As a community leader in sustainability, the Naperville Park District adopts various practices that is beneficial to the environment. Join Bailey Arnold of the American Lung Association, as well as Clint Burnell and Lee Meyer from the Naperville Park District discuss biodiesel fuel and the purpose of the B20 Club.

Happy New Year from Air Health Our Health! I share a brief reflection on the difference between knowledge and wisdom as well as how to move forward in 2025. To Do-  Pick an area for clean air, climate or tobacco action in the next year Flavored e-cigs, Tobacco Pollution & More? Listen to Sierra Club episodes, Season Three episodes w/ Dr. Jaspers and Dr. Jordt, and Season Two Heartbreaking Trap episode and more! Find out whether old diesel school engines have been cleaned up, and if not, advocate for that in your area. Listen to School Bus episode for more information! Plant trees! Learn about benefit with “Tree Lined vs Red Lined” episode from Season One Increase EV infrastructure - learn about health benefits in “Road to Clean Air” episode  There are many episodes on how to just get started- if you want inspiration, listen to the Clean Air and Climate Action for Busy People  or the Your Little Grain of Sand episode from Season Four. Make sure you are breathing healthy air in your own home!  Learn about: Radon- many episodes Gas appliances- “Fire Inside” Episode Stop smoking and vaping indoors and in general- ALA can help! Consider a donation to the American Lung Association, which does so much in the fight for clean air, climate action and tobacco control.  Finally, if you are so inspired, please leave the podcast a 5 star review wherever you get your podcasts and share an episode with a friend. Spread the word! Tomato Photo by Davies Designs Studio on Unsplash

For a probing discussion detailing the American Lung Association's recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targeted mutations, Dr. Sands addresses how precision oncology is fundamentally changing lung cancer diagnosis and treatment. The novel immunotherapy drugs, though proven to be safe and effective with significant improvements in response and survival rates, have challenges as well—this episode covers the gamut. Episode Highlights 0:00 Start 1:00 Topic of discussion 2:42 Introducing Jacob Sands, MD 3:39 NCCN guidelines for lung cancer 6:51 Recently-approved drugs for lung cancer 13:46 Patient responses to targeted mutations 17:58 Off-target side effects with drugs 21:34 State of Lung Cancer report 23:04 Estimated number of candidates for targeted therapies 26:13 Insurance coverage for biomarker testing 28:12 Other issues with ordering biomarkers 31:20 Closing comments 32:36 Outro Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Iowa ranks 39 out of 49 states for new rates of lung cancer, according to a new report from the American Lung Association. Simpson College students are researching how cells respond to changes to gravity with help from a NASA grant. And about 60 percent of Iowa communities experience a shortage of mental health care.

The American Lung Association just dropped its "State of Lung Cancer" report. The data looks at how lung cancer varies by state. How did Connecticut fare? Dr. Roy Herbst, lung cancer physician and expert at Yale Cancer Center gave us some key takeaways for our state. For the full CT report: https://www.lung.org/research/state-of-lung-cancer/states/connecticut Image Credit: Getty Images

1. The big demo machines are moving in, to take down Northridge Mall. 2. A new report from the American Lung Association suggests that not enough Americans are getting lung cancer screenings. 3. Ahead of the holiday season, the list is out for the worst toys of 2024, due to choking hazards and other dangers.

Discover how fitness expert Brittney Stracener Everett balances being a female entrepreneur with family life in this inspiring conversation about personal growth and professional success. Learn valuable insights about blending families, setting boundaries with social media, and maintaining authenticity in the digital age. Stay Fit Britt shares her journey from single mom to successful business owner, offering hope and practical strategies for women building their empire.   (01:19) Britt's Early Life and Fitness Journey  (04:28) Transition to a Healthier Lifestyle  (07:02) Balancing Personal and Professional Life  (12:37) Virtual Fitness and Social Media Impact  (20:34) Family Dynamics and Parenting Challenges  (29:27) Blending Families  (34:07) Overcoming Personal Patterns and Struggles  (42:50) Daily Routines and Self-Care  (46:49) Handling Criticism and Staying Authentic  (49:13) The Importance of Being Present  (53:31) Final Thoughts and Reflections  About Our Featured Charity:   This season, Alex Perry On Fire is making a monetary contribution to each guest's charity of choice. Brittney Stracener Everett's charity of choice is The American Lung Association. For 120 years, people living in America have trusted The American Lung Association to protect their lungs, whether it's researching treatments and cures for lung diseases, keeping kids off tobacco, including e-cigarettes, or advocating for laws that protect the air we all breathe.    Their goals are big—defeat lung cancer, create a tobacco-free future, champion clean air for all, and improve the quality of life for those living with lung disease.     Your turn to start the fire.   Like what you heard today on Alex Perry on Fire? Tell us about it. Want to share what has helped you on your journey? We want to hear about that, too.   Comment on social, DM us or give us a call.    Instagram: @alexperryonfire       TikTok: @alexperryonfire   Call: 214-506-8023  

We kicked off the program with four news stories and different guests on the stories we think you need to know about!Annual Boston Lung Force Walk American Lung Association's LUNG FORCE Walk Boston with Ashley Carrier - Executive Director in Massachusetts for American Lung Association.Cybersecurity Awareness Month - From romance scams to phishing scams, the cost of online threats is on the rise - online safety and the best ways to keep your information safe. With Kimberly Samra, Google Security Expert.Titanic: The Artifact Exhibition with Joe Gold who helped produce TITANIC: The Artifact Exhibition.20 things still made in Massachusetts! With Scott Kirsner – Boston Globe Contributor.Ask Alexa to play WBZ NewsRadio on #iHeartRadio!

The American Lung Association, with WGN Radio, shine a light on four remarkable Chicago women leaders at the Outstanding Mother Awards Dinner, presented by UChicago Medicine, at the Ivy Room on November 12th. Congratulations to Kelly Dittman of Sustene Global, who joined Lisa Dent to talk about balancing her professional career and caring for her […]

So far in 2024 there have been 100 diagnosed cases of tuberculosis in Minnesota. TB is a highly contagious disease that was at one time the leading cause of death across the country. You probably don't hear about TB much anymore. In Minnesota, that's thanks in no small part to Dr. Kathleen Jordan. She worked to detect the illness in children early — before it became active and contagious. As one local historian tells it, Dr. Jordan gave out more than 1.5 million tuberculosis skin tests throughout her career. In September, an exhibit and series of events in Granite Falls will honor that work. For more on the doctor's story, Peggy Kvam of the Dr. Kathleen Jordan Project and Jill Heins, a national senior director with the American Lung Association, joined Minnesota Now.

According to the American Lung Association, 1/3 of Americans have an environmental risk factor that may contribute to their asthma, COPD, lung cancer, allergies, and heart disease due to our current air quality. Since we can't control air pollution or wildfires, we can try to reduce the burden on our lungs and to reduce our inflammation from the inside out. And since this is a nutrition podcast, we're going to talk about foods and nutrients that can help keep our airways healthy and support our immune system. Join our two dietitians as they give some practical tips on supporting lung health!